Qualified Small Business Stock (QSBS)

In this episode of Weaver: The Alternative Edge, hosts Blayne Lowary and Vardeep Mann delve into the intricacies of Qualified Small Business Stock (QSBS). This conversation provides crucial information for investors and fund managers looking to maximize tax benefits through QSBS. Lowary and Mann bring valuable insights into how QSBS can be a significant advantage for non-corporate taxpayers, providing substantial exclusions on capital gains.

Key Points:

  • QSBS can provide substantial tax exclusions, potentially excluding up to $40 million of gain from taxable income.
  • Claiming QSBS benefits requires proper documentation and portfolio company representation.
  • Investors should be aware of pitfalls like warehouse investments and subsequent closes, which may disqualify QSBS eligibility.

 

 

Lowary and Mann discuss the key aspects and potential challenges of Qualified Small Business Stock (QSBS). They emphasize the importance of understanding QSBS eligibility criteria, including the need for proper documentation and portfolio company representations. “One of the requirements for stock to be eligible for QSBS is it has to be received upon original issuance,” Lowary said.

Additionally, the discussion covers critical gray areas, such as the impact of convertible notes and SAFEs on QSBS eligibility and the complexities surrounding carried interest. “Convertible notes and SAFEs are a gray area, specifically regarding when the clock starts for the five-year hold period,” Mann said. This episode serves as an essential guide for those navigating the QSBS landscape.

Subscribe and listen to future episodes of Weaver: The Alternative Edge, on Apple Podcasts or Spotify.

©2024

Follow us on social media for the latest updates in B2B!

Image

Latest

Care Anywhere: The Journey Begins
Care Anywhere: The Journey Begins
September 18, 2024

In the inaugural episode of Care Anywhere: The Global Health Workforce Podcast, host Lea Sims, CMO of CGFNS International, Inc., introduces the organization’s mission to address global healthcare workforce challenges. Joining the discussion are Dr. Peter Preziosi, President and CEO of CGFNS International, Inc., and Julia To Dutka, Chief of the CGFNS Global Health Workforce…

Read More
revolutionizing drug development
Revolutionizing Drug Development: The Patient Voice is Leading the Way!
September 18, 2024

Revolutionizing drug development is pivotal in today’s healthcare landscape, particularly as the patient voice grows louder and more influential in shaping therapies. The latest episode of Healthcare Rethink, a FinThrive podcast, looks at this transformative trend. In an engaging discussion, host Brian Urban welcomes Wendy Erler, the VP of Global Patient Experience at Alexion…

Read More
we matter
We All Deserve to Feel We Matter: Insights from Stephen “Shed” Shedletzky
September 17, 2024

In today’s fast-paced business environment, ensuring we matter at work is more important than ever. Research reveals that an employee’s relationship with their boss can impact their well-being more than their doctor or spouse, proving that leaders play a crucial role in shaping an environment where we matter. Stephen “Shed” Shedletzky, a Leadership Expert…

Read More
brand-agency
The Future of Brand-Agency Dynamic in the Age of AI
September 17, 2024

Hosted by Aby Varma, founder of Spark Novus, this episode of The Marketing AI SparkCast features David DeWolf, CEO of Knownwell. They discuss how AI reshapes brand-agency relationships, blending human creativity with AI’s efficiency to manage agency collaborations. In this episode of The Marketing AI SparkCast, Aby Varma, founder of Spark Novus—a company that…

Read More